SUMMARY Thirty-two patients were studied before and after i.v. administration of 0.150.20 mg/kg of propranolol. Twenty-one of the 32 underwent combined autonomic blockade with the additional infusion of 0.04 mg of atropine. Twenty other patients with sinus node disease underwent electrophysiologic studies both before and after i.v. administration of 0.04 mg of atropine alone. Spontaneous cycle length, maximal corrected sinus node recovery time, sinoatrial conduction time, secondary pauses and intrinsic heart rate were measured. Secondary pauses were more common in those with abnormal intrinsic heart rates, and they did not correlate with changes in maximal corrected sinus node recovery time or sinoatrial conduction time. In patients with normal intrinsic heart rate, abnormal test measurements usually returned to normal after combined blockade (hypervagotonia); however, some patients showed a new abnormality after propranolol that was not reversible with atropine (catecholamine-dependent). Abnormal test responses in patients with abnormal intrinsic heart rate persisted or increased after combined blockade. We conclude that patients with sinus node disease may be categorized as (1) those with intrinsic sinus node disease; (2) those with normal intrinsic sinus node function but either relative hypervagotonia or catecholamine dependency; and (3) those with abnormal intrinsic sinus node function affected by vagal or catecholamine factors.
CLINICAL EVALUATION of patients with electrocardiographic evidence of sinus node dysfunction is difficult because of the interplay of intrinsic sinus node disease and autonomic nervous system tone.'-6 Jordan et al.? suggested that measurement of the intrinsic heart rate might be of value for distinguishing patients with disturbances of autonomic nervous system tone from those with intrinsic sinus node dysfunction. One of the objectives of our report is to extend their observations of the relative contribution of sympathetic and vagal influences in patients with symptomatic sinus node disease.
Recently, Benditt et al.6 described the secondary pause (2°P) phenomenon or abnormal prolongation of postpacing cycles 2-10 in patients with sinus node disease. They demonstrated that evaluation of postpacing cycles 2-10 increased the value of atrial pacing tests in that patients with sinus node dysfunction may show the 2°P phenomenon in the presence of normal sinus node recovery time and sinoatrial conduction time (SACT). The role of autonomic tone in unmasking or suppressing this phenomenon has not been studied in detail, and such information might clarify the mechanisms of the 2°P phenomenon.
A second objective of this study is to evaluate the effects of vagolysis, 0 blockade and combined autonomic blockade on the 2°P phenomenon.
Materials and Methods
The study group consisted of 52 patients with clinical features of sinus node dysfunction. Patients included for study were those with persistent sinus bradycardia, sinoatrial block, sinus pauses or the bradycardia-tachycardia syndrome. The pertinent clinical data are presented in tables 1 and 2.
All subjects gave informed written consent according to protocol approved by the Committees on Human Research at the University of California, San Francisco, and Duke University Medical Center.
Studies were performed in a cardiac catheterization laboratory with the patient in a nonsedated, postabsorptive state. All cardiac drugs were terminated before catheterization by an interval that exceeded three half-lives of any agent. Two nmultipolar electrode catheters were inserted into the right femoral vein. One catheter was positioned at the junction of the superior vena cava and high right atrium for atrial pacing and recording and the other was positioned across the tricuspid valve for recording the His bundle potential. Multiple surface leads were displayed simultaneously with those of the intracardiac ECGs on an oscilloscope and recorded on a DR-8 Electronics for Medicine recorder or an Elema Mingograf 800 recorder.
Study Protocol
After a 20-minute stabilization period, control recordings were obtained. Atrial overdrive pacing was instituted for 60 seconds at a cycle length of 100-200 msec below the spontaneous cycle length, and 10 con- Mean  973  676  164  746  588  116  SD  -227  =851  =85  =198  =1141  100 Values in italics represent abnormal responses.
Abbreviations: A = absent; BTS = bradytachycardia syndrome; CHF = congestive heart failure; CSNRTm = maximal corrected sinus node recovery time; P = present; SACT = sinoatrial conduction time; SAEB = sinoatrial exit block; SB = sinus bradycardia; SCL = spontaneous cycle length; CP = chaotic pattern; 2°P = secondary pauses.
secutive cycles were recorded after abrupt termination of pacing. Pacing runs were repeated with 50-60-msec decrements in paced atrial cycle length until a paced minimum cycle length of 350 msec was reached.8 Forty-five-second rest periods were allowed between each pacing run. The first postpacing cycle length (sinus node recovery time) and postpacing cycles 2-10 were determined after 1 minute of pacing at each paced cycle length, as described previously.8 Programmed atrial stimuli were then introduced during spontaneous rhythm, and the coupling interval was decreased in 10-msec decrements throughout the excitable portion of the atrial diastolic cycle until atrial refractoriness was achieved.9
These pacing studies were performed before and after i.v. administration of atropine, 0.04 mg/kg, in 20 subjects. In a separate group of 32 subjects, studies were performed before and after i.v. administration of propranolol, either 0. 15 10 In the absence of drugs, the upper limit of the normal range for total antegrade and retrograde conduction in our laboratories is 206 msec.11 A chaotic return pattern'12 13 in the absence of marked sinus arrhythmia was considered abnormal. Mean spontaneous cycle length was determined from 20 consecutive cycles before and after each intervention. The maximal sinus node recovery times determined from the multiple pacing runs were used for data analysis. Postpacing cycle lengths 2-10 were normalized by the spontaneous cycle length and 2°Ps were defined according to criteria reported by Benditt et The observed heart rates after combined blockade (intrinsic heart rate) were compared with those predicted from normal subjects using the formula of Frick et al.'7 (predicted intrinsic heart rate = 120 -[0.58 + age] ± 8.1). We used this formula, rather than the one used by Jose and Collison,18 because it contained more subjects in the same age range as our patient population. The intrinsic heart rate was considered abnormal if it fell below 2 standard deviations from the predicted value. The data are expressed as mean ± SD unless otherwise specified. Differences were evaluated using the t test.
Results

Patient Classification
The patients given i.v. atropine (table 1) or  propranolol (table 2) were further subdivided on the basis of the predominant electrocardiographic abnormalities. These groupings included chronic sinus bradycardia, sinus pauses or sinoatrial exit block and bradycardia-tachycardia syndrome. The incidence of abnormal responses was compared among these three groups. Spontaneous cycle length was significantly longer in patients in the sinus bradycardia group (1086 ± 204 msec) compared with either those with predominant sinoatrial pauses or exit block, 902 ± 146 msec (p < 0.05), or those with the bradycardiatachycardia syndrome, 928 + 186 msec (p < 0.05). There was no significant difference in the incidence of any specific abnormal test response among the groups. However, patients with bradycardia-tachycardia syndrome had a higher composite abnormal test response, 1.2 ± 0.7 abnormal responses/patient, than the sinus bradycardia group, 0.6 ± 0.9 abnormal responses/patient (p < 0.05).
Effects of Autonomic Blockade on Secondary Pauses
Effects ofAtropine Twenty patients were studied before and after administration of atropine, 0.04 mg/kg ( patients developed abnormal values for SACT after drug administration. The changes in incidence of abnormal CSNRTm or SACT after atropine were not statistically significant. Secondary pauses were present in 13 of 20 patients under control conditions and disappeared after atropine in eight of 13, so 2°Ps were present only in five of 20 patients after the drug. The decrease in incidence of 2°P after atropine was statistically significant (p < 0.02). Therefore, although atropine resulted in a decreased incidence of 2°P, associated changes in CSNRTm and SACT were variable.
Effects of Propranolol
Thirty-two patients were studied before and after i.v. infusion of propranolol, 0.15 or 0.2 mg/kg (table  2) . The CSNRTm during control conditions was abnormal in six of 32 patients; after propranolol, it was abnormal in nine of 32 patients; CSNRTm became normal in one and abnormal in four other patients. The SACT measured under control conditions was abnormal in 14 of 31 patients (not measured in one). After propranolol, 13 of 31 had abnormal values; SACT became normal in four and abnormal in three more patients. Thirteen of 32 patients had 2°P during control conditions. After propranolol, 15 of 32 patients had 2°P; 2°P was abolished in two and appeared in five additional patients.
For the group as a whole, the incidence of 2°P did not change significantly after propranolol, nor did the changes in 2°P correlate with changes in CSNRTm or SACT.
Effects of Combined Blockade
The electrophysiologic effects of combined blockade were assessed in 21 patients ( abnormal in three and could not be measured in one of the four after atropine. No new abnormalities in SACT were induced after combined blockade. In subjects with normal intrinsic heart rates, control SACT was abnormal in four of 13 subjects, but normalized in two after propranolol. After combined blockade, only one patient had an abnormal SACT.
Secondary Pauses
The incidence of 2°P was significantly higher in patients with abnormal intrinsic heart rates compared with those with normal intrinsic heart rates during the control period (five of eight vs two of 13) (p < 0.05) and after combined blockade (six of eight vs one of 13) (p < 0.005). Two patients with normal intrinsic heart rates had 2°Ps in the control period. After propranolol, 2°Ps disappeared in one but manifested in three additional subjects. After combined blockade, only one patient had a 2°P. In contrast, five of eight patients with abnormal intrinsic heart rates had 2°Ps; one additional patient had 2°Ps after propranolol that disappeared after atropine administration. Thus, 2°Ps were common in patients with abnormal intrinsic heart rates either before (five of eight patients) or after combined blockade (six of eight patients). Secondary pauses occurred less frequently in the group with normal intrinsic heart rates either before (two of 13) or after combined blockade (one of 13 patients).
Total Test Abnormalities
Striking differences were apparent between the groups with normal vs abnormal intrinsic heart rates. In the 13 patients with normal intrinsic heart rates, eight abnormal tests were recorded. After combined blockade, only two abnormal tests were detected. Patients with abnormal intrinsic heart rates had 1 1 abnormal test responses in eight subjects. After combined blockade, 16 abnormal test responses were recorded in those patients. There was no significant difference in the incidence of total abnormal test responses under control conditions between patients with normal and abnormal intrinsic heart rates; however, the incidence of abnormal total test responses was greater in the group with abnormal intrinsic heart rates (eight of 16 vs two of 13) after combined blockade (p < 0.005). Thus, combined blockade (especially after vagolysis) tended to normalize test responses in patients with normal intrinsic heart rates, whereas combined blockade resulted in an increased incidence of abnormal test responses in patients with abnormal intrinsic heart rates.
Discussion Secondary Pauses
Benditt et al.8 described abnormal prolongation of atrial overdrive postpacing cycles 2-10 as 2°Ps. The basic mechanism of this abnormality is unknown but may be related in part to abnormalities in automaticity, sinoatrial conduction, intranodal block or intranodal oscillatory potentials that fail to reach threshold.19 ' 20 Regardless of the underlying mechanism, the effects of vagolyses and fl blockade on 2°P are apparent in our study. Although our data suggest a vagal and a catecholamine component in the 2°P phenomenon, the different responses may mainly have been caused by the presence or absence of intrinsic sinus node disease. We found that 2°Ps occurred frequently in patients who had an abnormal intrinsic heart rate and persisted or increased in frequency after combined blockade in these patients. In contrast, only two of 13 patients with normal intrinsic heart rates had 2°Ps, and those abnormalities (along with other abnormal test responses) tended to normalize after combined blockade. Although too few patients were studied to draw definitive conclusions, combined blockade apparently exerted little effect on patients with 2°Ps and intrinsic sinus node disease (i.e., those with abnormal intrinsic heart rates). In summary, 2°Ps appear to be predominantly an expression of intrinsic sinus node dysfunction, but in selected patients both a vagal and a catecholamine component appeared to be important (table 2) . We found no correlation, however, between abolition or persistence of 2°Ps with changes in either sinus node automaticity or sinoatrial conduction.
Normal Intrinsic Heart Rates and Changes in Specific Electrophysiologic Measurements
Our data confirm and extend the observations of Jordan et al.7 Like Jordan et al., we found that abnormalities in CSNRTm were uniformly abolished after combined blockade in patients with normal intrinsic heart rate. However, the effects of combined blockade on other measurements of sinoatrial function, as well as the serial studies after propranolol and atropine, led to further insights into the relationship of the autonomic nervous system and sinus node function. In five of the 13 subjects with normal intrinsic heart rates, abnormalities present either during control observations or after propranolol disappeared after atropine. We interpret this finding as a relative hypervagotonic response and suggest that the clinical features of the sick sinus syndrome in these subjects may have been related to vagal overreactivity. In addition, vagolysis resulted in significant decreases in both CSNRTm and SACT in this patient subgroup. The important effects of acetylcholine on sinus node automaticity21 and refractoriness are well established. 22 In contrast, two of 13 patients with normal intrinsic heart rate still showed abnormal test responses after combined blockade and warrant further comment. In patient 8, abnormalities provoked by propranolol persisted after vagolysis (table 2) . Similarly, patient 6, who had abnormal control SACT, had a marked increase in SACT after propranolol that failed to normalize after atropine. We believe these findings are suggestive of catecholamine dependency. There is strong evidence for an obligatory role of catecholamines on cardiac pacemakers.23 25 In several patients, 958 CIRCULATION AUTONOMIC BLOCKADE IN SINUS NODE DISEASE/Desai et al.
both a catecholamine-dependent factor and a vagal factor appeared to be operative. Whether this reflects increased end-organ sensitivity or increased release of acetylcholine from the nerve terminals is not established by this study; either would produce a beneficial response to atropine.
Abnormal Intrinsic Heart Rates and Specific Electrophysiologic Measurements Like Jordan et al., 7 we found more abnormal test responses after combined blockade in patients with abnormal than in those with normal intrinsic heart rates. Jordan et al. interpreted their findings as suggesting that those subjects with abnormal intrinsic heart rates had intrinsic sinus node disease that was relatively unaffected by pertubations in autonomic tone. However, the pattern of response after propranolol and atropine in our study suggests an important additive role of the autonomic nervous system in these patients. For example, an abnormal CSNRTm was provoked after propranolol in patients 14 and 19 and remained abnormal after atropine. We interpret this finding to be superimposed catecholamine dependency. In contrast, patients 21 and 16 had 2°P during control studies or after propranolol that were abolished after atropine. We believe that this was probably due to the additive influence of relative hypervagotonia. Somewhat more difficult to explain is the provocation of abnormal CSNRTm in patients 16, 17 and 20 only after atropine. Prior fA blockade appeared to sensitize these subjects to paradoxic lengthening of the CSNRTm after atropine;26 the cause of this response is not known.
Our data must be interpreted in the presence of serious limitations in the methods of assessing sinus node function. The problems related to measurements of SACT have been well described elsewhere.27 In addition, normalization or provocation of an abnormality must be interpreted in terms of the total electrophysiologic response. For example, apparent normalization of SACT after propranolol does not necessarily suggest improved sinoatrial conduction but may occur as a result of sinus slowing or pacemaker shift.28 In addition, provocation of an abnormal CSNRTm after atropine does not necessarily reflect depression of automaticity but instead improved sinoatrial conduction with more effective pacemaker suppression after atrial overdrive pacing.29
In our study the same population of patients was not tested with two different protocols, so differences in patient characteristics rather than altered autonomic tone might explain our findings. This hypothesis must therefore be tested in larger patient cohorts in whom the intrinsic heart rate is known.
In conclusion, patients broadly labeled as having the sick sinus syndrome can be more accurately categorized into three broad subgroups: (1) those with normal intrinsic sinus node function but with relative hypervagotonia; (2) those with intrinsic disease whose sinus node function is affected by changes in autonomic nervous system tone; and (3) those with intrinsic sinus node dysfunction unaffected by changes in autonomic tone. This categorization could lead to more rational treatment programs for patients with sinus node dysfunction. Intracoronary injection of veratridine produced bradycardia, hypotension and gastric dilation. Decreases in heart rate and increases in gastric volume produced by injection of veratridine into the circumflex artery were greater than those that resulted from injection into the anterior descending artery (32 ± 10 ml vs 14 ± 5 ml, respectively; p < 0.05). Flow in these two beds and the weight of myocardium perfused by each vessel were not different.
Diaphragmatic vagotomy abolished the gastric response but not the bradycardic or hypotensive response to intracoronary injection of veratridine. Intracoronary administration of lidocaine and bilateral cervical vagotomy blocked all reflex responses to intracoronary veratridine.
Stimulation of cardiac receptors with vagal afferent pathways by veratridine in the dog evokes reflex gastric and circulatory responses in anesthetized dogs. These responses are greater during stimulation of cardiac receptors in the inferoposterior wall. A similar reflex may contribute to the nausea and vomiting in the early stages of inferoposterior myocardial infarction.
NAUSEA AND VOMITING are common symptoms in patients with acute myocardial infarction. They are more common in patients with inferoposterior infarction than in those with anterior infarction.' Ahmed et al. reported that in 62 patients with documented myocardial infarction and gastrointestinal symptoms before administration of analgesics, 69% of the patients with inferoposterior in-farction reported a history of nausea and vomiting, while only 27% with anterior infarction experienced these symptoms.' This difference could not be explained by differences in severity of pain or the presence of shock. Thus, other mechanisms must play an important role in the pathogenesis of nausea and vomiting in these patients.
The gastrointestinal symptoms in patients with inferior infarction are often associated with bradycardia.' The high frequency of bradycardia and hypotension during inferior infarction may result from stimulation of cardiac sensory receptors that mediate cardioinhibitory and vasodepressor responses.2 These sensory receptors may be preferentially distributed in the inferoposterior wall of the left ventricle.3. 4 Abrahamsson and Thor6n have reported that stimulation of cardiac receptors with vagal afferents by veratridine or ischemia in unanesthetized, decerebrate cats produces reflex gastric relaxation as
